<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T01:13:27Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/8792" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/8792</identifier><datestamp>2026-09-24T06:04:55Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Sebaldt, Rolf J.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Marignani, Paola A.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Medical Sciences</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2014-06-18T16:44:00Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2014-06-18T16:44:00Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="created" lang="en_US">2011-03-15</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">1996-08</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">opendissertations/3967</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">4984</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">1876006</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/8792</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/22346</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">&lt;p>The focus of my thesis was to investigate changes in the formation of&lt;br />second messenger sn-1,2-diradylglycerol (DG) and phospholipids (PL) in murine&lt;br />peritoneal macrophages in vitro and in vivo in response to varying concentrations&lt;br />of the 3-olyunsaturated fatty acids ([symbol removed]3PUFA), eicosapentaenoic (EPA, 20:5[symbol removed]3) and docosahexaenoic (DHA, 22:6[symbol removed]3) acids. My findings establish for the first time that the incorporation of EPA and DHA into DG and membrane PL occurs&lt;br />independently and dose-dependently, with EPA being incorporated to a greater&lt;br />extent than DHA.&lt;/p> &lt;p>It was of interest to investigate the functional correlations of the substitution&lt;br />of [symbol removed]3PUFA into DG and PL molecular species. DG is classically known as the physiological activator of protein kinase C (PKC). I investigated the effects on&lt;br />PKC activation by pure species of diacylglycerol (DAG) with oleoyl, arachidonoyl,&lt;br />eicosapentaenoyl or docosahexaenoyl at the sn-2 position. These results showed&lt;br />that DG species with DHA or EPA incorporated at the sn-2 position activate PKC.&lt;br />However, while DG with DHA at the sn-2 position activated PKC to a similar&lt;br />extent as did DG with AA at the sn-2 position (representative of physiological DG),&lt;br />DG with EPA at the sn-2 position activated PKC to a significantly lesser degree.&lt;br />To the best of my knowledge, this is the first demonstration in the literature that the activation of PKC in vitro differs significantly among these molecular species&lt;br />of DAG.&lt;/p> &lt;p>The immunoregulatory cytokine, interleukin-6 (IL-6), is produced in&lt;br />response to tissue injury and inflammation and in vitro by LPS-stimulated&lt;br />macrophages. I investigated the correlation of [symbol removed]3PUFA substitution into DC and&lt;br />secretion of IL-6 by LPS-stimulated murine peritoneal macrophages. These results&lt;br />show for the first time that IL-6 secretion is attenuated by [symbol removed]3PUFA, and to a&lt;br />greater extent by DHA than by EPA.&lt;/p> &lt;p>I have obtained several novel findings that contribute to improved&lt;br />understanding of the underlying mechanisms by which [symbol removed]3PUFA function at the&lt;br />level of signal transduction. The ability to modify the fatty acid composition of the&lt;br />signalling molecule, DG, with [symbol removed]3PUFA can now be used for future research to&lt;br />further elucidate the functional ramifications of [symbol removed]3PUFA in cell signal&lt;br />transduction.&lt;/p></dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Doctor of Philosophy (PhD)</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">EFFECTS OF [symbol removed]3-POLYUNSATURATED FATTY ACIDS ON TIlE FORMATION OF sn-1,2-DIRADYLGLYCEROL, CYTOKINE SECRETION AND THE REGULATION OF PROTEIN KINASE C ACTIVITY</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>